Physician profile
Roger C Willis
NPI 1477501815
$258.01
in general payments reported to CMS, 2019-2025
8 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.29 · 2020: $26.71 · 2023: $15.50 · 2024: $62.72 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $106.25 | 2025 | Rexulti |
| Novo Nordisk INC | $59.44 | 2023-2024 | Ozempic, Rybelsus |
| Biocryst US Sales Co., LLC | $20.54 | 2025 | Orladeyo |
| Exact Sciences Corporation | $18.78 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $13.90 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.54 | 2019 | |
| Lilly USA, LLC | $12.81 | 2020 | |
| Pfizer INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.